100 related articles for article (PubMed ID: 6129649)
21. Long term treatment of tardive dyskinesia.
Jus A; Jus K; Fontaine P
J Clin Psychiatry; 1979 Feb; 40(2):72-7. PubMed ID: 33156
[TBL] [Abstract][Full Text] [Related]
22. Comparison of severe and mild tardive dyskinesia: implications for etiology.
Gardos G; Cole JO; Schniebolk S; Salomon M
J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
[TBL] [Abstract][Full Text] [Related]
23. [For how long should antipsychotic medication be continued after the first psychotic episode in schizophrenics?].
van Harten PN; Hoek HW
Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1361-4. PubMed ID: 9752021
[TBL] [Abstract][Full Text] [Related]
24. [Tardive dyskinesia induced by neuroleptics. A review of the literature].
Diepart E; Cottereau MJ; Deniker P
Encephale; 1979; 5(4):317-37. PubMed ID: 42528
[TBL] [Abstract][Full Text] [Related]
25. [Beta blockade with celiprolol in tardive dyskinesia patients treated with neuroleptics].
Hebenstreit GF; Hoffmann H; Hoffmann W; Pittner H
Wien Klin Wochenschr; 1986 Jun; 98(12):388-92. PubMed ID: 2874663
[TBL] [Abstract][Full Text] [Related]
26. Vulnerability to tardive dyskinesia.
Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
[TBL] [Abstract][Full Text] [Related]
27. The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics.
Spohn HE; Coyne L
Brain Cogn; 1993 Sep; 23(1):28-39. PubMed ID: 8105820
[TBL] [Abstract][Full Text] [Related]
28. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
Bai YM; Yu SC; Lin CC
J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
[TBL] [Abstract][Full Text] [Related]
29. Tardive dyskinesia and impaired glucose tolerance.
Chong SA; Mythily ; Lum A; Huak CY; Kane J
Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
[TBL] [Abstract][Full Text] [Related]
30. Tiapride in the treatment of tardive dyskinesia: a clinical and biochemical study.
Perényi A; Arató M; Bagdy G; Frecska E; Szücs R
J Clin Psychiatry; 1985 Jun; 46(6):229-31. PubMed ID: 2860098
[TBL] [Abstract][Full Text] [Related]
31. Lithium in tardive dyskinesia.
Simpson GM; Branchey MH; Lee JH; Voitashevsky A; Zoubok B
Pharmakopsychiatr Neuropsychopharmakol; 1976 Mar; 9(2):76-80. PubMed ID: 790411
[TBL] [Abstract][Full Text] [Related]
32. Bromocriptine and CF 25-397 in the treatment of tardive dyskinesia.
Tamminga CA; Chase TN
Arch Neurol; 1980 Apr; 37(4):204-5. PubMed ID: 6102461
[TBL] [Abstract][Full Text] [Related]
33. Gamma-Acetylenic GABA in tardive dyskinesia.
Casey DE; Gerlach J; Magelund G; Christensen TR
Adv Biochem Psychopharmacol; 1980; 24():577-80. PubMed ID: 6105803
[TBL] [Abstract][Full Text] [Related]
34. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
Kocher R; Hobi V; Linder M; Studer K
Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):103-9. PubMed ID: 6106283
[TBL] [Abstract][Full Text] [Related]
35. [Neuroleptic-induced movement disorders: historical perspectives].
Wolf MA; Yassa R; Llorca PM
Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
[TBL] [Abstract][Full Text] [Related]
36. Clinical and epidemiologic aspects of tardive dyskinesia.
Baldessarini RJ
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
[TBL] [Abstract][Full Text] [Related]
37. Tardive dyskinesia, impaired recall, and informed consent.
Ganguli R; Raghu U
J Clin Psychiatry; 1985 Oct; 46(10):434-5. PubMed ID: 2864333
[TBL] [Abstract][Full Text] [Related]
38. Treatment of tardive dyskinesia with bromocriptine. A test of the receptor modification strategy.
Lieberman JA; Alvir J; Mukherjee S; Kane JM
Arch Gen Psychiatry; 1989 Oct; 46(10):908-13. PubMed ID: 2572205
[TBL] [Abstract][Full Text] [Related]
39. Tardive dyskinesia: clinical and neuroendocrine response to low dose bromocriptine.
Lenox RH; Weaver LA; Saran BM
J Clin Psychopharmacol; 1985 Oct; 5(5):286-92. PubMed ID: 4044881
[TBL] [Abstract][Full Text] [Related]
40. Clonidine trial in tardive dyskinesia. Therapeutic response, MHPG, and plasma DBH.
Tripodianakis J; Markianos M
Pharmacopsychiatry; 1986 Sep; 19(5):365-7. PubMed ID: 3534900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
